Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2003Journal of Bone and Mineral ResearchOpen Access

12-O-tetradecanoylphorbol-13-acetate (TPA) Inhibits Osteoclastogenesis by Suppressing RANKL-Induced NF-κB Activation

View Full Paper
Ask AI
Bookmark
Share

Authors

CWCathy WangWestern UniversityJSJames H. SteerThe University of Western AustraliaDJDavid A. JoyceThe University of Western Australia

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2003) studied this question.

synapsesocial.com/papers/6a7f37d4b5ccfbbe2d84ef51https://doi.org/10.1359/jbmr.2003.18.12.2159
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mice Lacking the Type I Interleukin-1 Receptor Do Not Lose Bone Mass after Ovariectomy1998 · 180 citations
  2. 2An in vitro transcription analysis of early responses of the human immunodeficiency virus type 1 long terminal repeat to different transcriptional activators.1991 · 80 citations
  3. 3Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity2002 · 213 citations
  4. 4Estrogen Decreases Osteoclast Formation by Down-regulating Receptor Activator of NF-κB Ligand (RANKL)-induced JNK Activation2001 · 360 citations